Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V (open house model)
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of this publication is the conclusion of agreements in accordance with Section 130a Paragraph 8 SGB V on finished medicinal products with various active ingredients or combinations of active ingredients within the framework of a so-called “open house model”. Joining or concluding a contract can take place at any time and under the same conditions. Individual contract negotiations will not be carried out. The earliest contract start date is January 1st, 2027. Based on this, the contract term is a maximum of 24 months. The contract ends on December 31, 2028, regardless of the start of the contract. Should the AOK